BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bergasa NV. The pruritus of cholestasis. J Hepatol. 2005;43:1078-1088. [PMID: 16253381 DOI: 10.1016/j.jhep.2005.09.004] [Cited by in Crossref: 82] [Cited by in F6Publishing: 58] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Bergasa NV. Lysophosphatidic acid and atotaxin in patients with cholestasis and pruritus: Fine biology, anticipated discernment. Annals of Hepatology 2010;9:475-9. [DOI: 10.1016/s1665-2681(19)31629-1] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Abbas G, Jorgensen RA, Lindor KD. Fatigue in primary biliary cirrhosis. Nat Rev Gastroenterol Hepatol. 2010;7:313-319. [PMID: 20458334 DOI: 10.1038/nrgastro.2010.62] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
3 Swain MG. Gastrin-releasing peptide and pruritus: More than just scratching the surface. Journal of Hepatology 2008;48:681-3. [DOI: 10.1016/j.jhep.2008.01.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
4 Reddy L, Krajnik M, Zylicz Z. Transdermal Buprenorphine May Be Effective in the Treatment of Pruritus in Primary Biliary Cirrhosis. Journal of Pain and Symptom Management 2007;34:455-6. [DOI: 10.1016/j.jpainsymman.2007.08.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
5 Hamilton JP, Laurin JM. Drug-Induced Cholestasis. In: Lindor KD, Talwalkar JA, editors. Cholestatic Liver Disease. Totowa: Humana Press; 2008. pp. 21-43. [DOI: 10.1007/978-1-59745-118-5_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
6 Paumgartner G, Pusl T. Medical treatment of cholestatic liver disease. Clin Liver Dis. 2008;12:53-80, viii. [PMID: 18242497 DOI: 10.1016/j.cld.2007.11.013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
7 Mayo MJ, Pockros PJ, Jones D, Bowlus CL, Levy C, Patanwala I, Bacon B, Luketic V, Vuppalanchi R, Medendorp S, Dorenbaum A, Kennedy C, Novak P, Gu J, Apostol G, Hirschfield GM. A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis. Hepatol Commun 2019;3:365-81. [PMID: 30859149 DOI: 10.1002/hep4.1305] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
8 Mettang T, Streit M, Weisshaar E. Pruritus bei inneren Erkrankungen. Hautarzt 2006;57:395-402. [DOI: 10.1007/s00105-006-1124-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
9 Hohenester S, Oude-Elferink RP, Beuers U. Primary biliary cirrhosis. Semin Immunopathol. 2009;31:283-307. [PMID: 19603170 DOI: 10.1007/s00281-009-0164-5] [Cited by in Crossref: 114] [Cited by in F6Publishing: 96] [Article Influence: 8.8] [Reference Citation Analysis]
10 Lasalle L, Rachelska G, Nedelec B. Naltrexone for the management of post-burn pruritus: A preliminary report. Burns 2008;34:797-802. [DOI: 10.1016/j.burns.2007.10.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
11 Welz-kubiak K, Reszke R, Szepietowski JC. Pruritus as a sign of systemic disease. Clinics in Dermatology 2019;37:644-56. [DOI: 10.1016/j.clindermatol.2019.07.031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
12 Matsuda KM, Sharma D, Schonfeld AR, Kwatra SG. Gabapentin and pregabalin for the treatment of chronic pruritus. Journal of the American Academy of Dermatology 2016;75:619-625.e6. [DOI: 10.1016/j.jaad.2016.02.1237] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 7.7] [Reference Citation Analysis]
13 Kremer AE, Martens JJ, Kulik W, Ruëff F, Kuiper EM, van Buuren HR, van Erpecum KJ, Kondrackiene J, Prieto J, Rust C. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology. 2010;139:1008-1018, 1018.e1. [PMID: 20546739 DOI: 10.1053/j.gastro.2010.05.009] [Cited by in Crossref: 252] [Cited by in F6Publishing: 213] [Article Influence: 21.0] [Reference Citation Analysis]
14 Düll MM, Kremer AE. Treatment of Pruritus Secondary to Liver Disease. Curr Gastroenterol Rep 2019;21. [DOI: 10.1007/s11894-019-0713-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
15 Costamagna G, Familiari P, Tringali A, Mutignani M. Multidisciplinary approach to benign biliary strictures. Curr Treat Options Gastro 2007;10:90-101. [DOI: 10.1007/s11938-007-0061-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
16 Carbone M, Bufton S, Monaco A, Griffiths L, Jones DE, Neuberger JM. The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective study. J Hepatol 2013;59:490-4. [PMID: 23628322 DOI: 10.1016/j.jhep.2013.04.017] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
17 Shneider BL, Mazariegos GV. Biliary atresia: a transplant perspective. Liver Transpl. 2007;13:1482-1495. [PMID: 17969203 DOI: 10.1002/lt.21303] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
18 Ikoma A, Steinhoff M, Ständer S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci 2006;7:535-47. [DOI: 10.1038/nrn1950] [Cited by in Crossref: 585] [Cited by in F6Publishing: 487] [Article Influence: 36.6] [Reference Citation Analysis]
19 Tajiri K, Shimizu Y. Recent advances in the management of pruritus in chronic liver diseases. World J Gastroenterol 2017; 23(19): 3418-3426 [PMID: 28596678 DOI: 10.3748/wjg.v23.i19.3418] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
20 Marschall H, Wagner M, Zollner G, Trauner M. Clinical Hepatotoxicity. Regulation and Treatment with Inducers of Transport and Cofactors. Mol Pharmaceutics 2007;4:895-910. [DOI: 10.1021/mp060133c] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
21 Trivedi PJ, Kumagi T, Al-harthy N, Coltescu C, Ward S, Cheung A, Hirschfield GM. Good Maternal and Fetal Outcomes for Pregnant Women With Primary Biliary Cirrhosis. Clinical Gastroenterology and Hepatology 2014;12:1179-1185.e1. [DOI: 10.1016/j.cgh.2013.11.030] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 5.1] [Reference Citation Analysis]
22 Liu T, Ji RR. New insights into the mechanisms of itch: are pain and itch controlled by distinct mechanisms? Pflugers Arch 2013;465:1671-85. [PMID: 23636773 DOI: 10.1007/s00424-013-1284-2] [Cited by in Crossref: 106] [Cited by in F6Publishing: 97] [Article Influence: 11.8] [Reference Citation Analysis]
23 Ho V, Stewart M, Boyd P. Cholestatic hepatitis as a possible new side-effect of oxycodone: a case report. J Med Case Rep 2008;2:140. [PMID: 18452597 DOI: 10.1186/1752-1947-2-140] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
24 Patel KN, Dong X. Itch: Cells, Molecules, and Circuits. ACS Chem Neurosci 2011;2:17-25. [PMID: 21720568 DOI: 10.1021/cn100085g] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
25 Pusl T, Denk GU, Parhofer KG, Beuers U. Plasma separation and anion adsorption transiently relieve intractable pruritus in primary biliary cirrhosis. J Hepatol. 2006;45:887-891. [PMID: 17046095 DOI: 10.1016/j.jhep.2006.08.008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
26 Bergasa NV, McGee M, Ginsburg IH, Engler D. Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial. Hepatology. 2006;44:1317-1323. [PMID: 17058231 DOI: 10.1002/hep.21370] [Cited by in Crossref: 69] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
27 Liu XY, Liu ZC, Sun YG, Ross M, Kim S, Tsai FF, Li QF, Jeffry J, Kim JY, Loh HH, Chen ZF. Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell 2011;147:447-58. [PMID: 22000021 DOI: 10.1016/j.cell.2011.08.043] [Cited by in Crossref: 169] [Cited by in F6Publishing: 159] [Article Influence: 15.4] [Reference Citation Analysis]
28 Ikoma A, Cevikbas F, Kempkes C, Steinhoff M. Anatomy and neurophysiology of pruritus. Semin Cutan Med Surg 2011;30:64-70. [PMID: 21767766 DOI: 10.1016/j.sder.2011.04.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
29 Parés A, Herrera M, Avilés J, Sanz M, Mas A. Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers. J Hepatol. 2010;53:307-312. [PMID: 20580987 DOI: 10.1016/j.jhep.2010.02.031] [Cited by in Crossref: 79] [Cited by in F6Publishing: 57] [Article Influence: 6.6] [Reference Citation Analysis]
30 Düll MM, Kremer AE. Newer Approaches to the Management of Pruritus in Cholestatic Liver Disease. Curr Hepatology Rep 2020;19:86-95. [DOI: 10.1007/s11901-020-00517-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Tominaga M, Takamori K. Recent advances in pathophysiological mechanisms of itch. Expert Review of Dermatology 2014;5:197-212. [DOI: 10.1586/edm.10.7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
32 Rerknimitr R, Kullavanijaya P. Operable malignant jaundice: To stent or not to stent before the operation? World J Gastrointest Endosc 2010; 2(1): 10-14 [PMID: 21160672 DOI: 10.4253/wjge.v2.i1.10] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
33 Carbone M, Neuberger J. Liver transplantation in PBC and PSC: Indications and disease recurrence. Clinics and Research in Hepatology and Gastroenterology 2011;35:446-54. [DOI: 10.1016/j.clinre.2011.02.007] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
34 Ostadhadi S, Haddadi N, Foroutan A, Azimi E, Elmariah S, Dehpour A. Development of resistance to serotonin-induced itch in bile duct ligated mice. Clin Exp Pharmacol Physiol 2017;44:680-5. [DOI: 10.1111/1440-1681.12752] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
35 Beuers U, Gerken G, Pusl T. Biliary drainage transiently relieves intractable pruritus in primary biliary cirrhosis. Hepatology. 2006;44:280-281. [PMID: 16799978 DOI: 10.1002/hep.21271] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
36 Tandon P, Rowe BH, Vandermeer B, Bain VG. The Efficacy and Safety of Bile Acid Binding Agents, Opioid Antagonists, or Rifampin in the Treatment of Cholestasis-Associated Pruritus. Am J Gastroenterology 2007;102:1528-36. [DOI: 10.1111/j.1572-0241.2007.01200.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 76] [Article Influence: 7.5] [Reference Citation Analysis]
37 Milkiewicz P. Liver Transplantation in Primary Biliary Cirrhosis. Clinics in Liver Disease 2008;12:461-72. [DOI: 10.1016/j.cld.2008.02.015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
38 Cevikbas F, Steinhoff M, Ikoma A. Role of spinal neurotransmitter receptors in itch: new insights into therapies and drug development. CNS Neurosci Ther 2011;17:742-9. [PMID: 20950328 DOI: 10.1111/j.1755-5949.2010.00201.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
39 Meng Y, Liang Y, Liu M. The value of MRI in the diagnosis of primary biliary cirrhosis and assessment of liver fibrosis. PLoS One. 2015;10:e0120110. [PMID: 25781184 DOI: 10.1371/journal.pone.0120110] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
40 Kremer AE, Feramisco J, Reeh PW, Beuers U, Oude Elferink RP. Receptors, cells and circuits involved in pruritus of systemic disorders. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2014;1842:869-92. [DOI: 10.1016/j.bbadis.2014.02.007] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
41 Zhong CS, Elmariah SB. Phototherapy for Itch. Dermatologic Clinics 2020;38:145-55. [DOI: 10.1016/j.det.2019.08.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
42 Cowan A, Inan S. Kappa-Opioid Antagonists as Pruritogenic Agents. In: Dean RL, Bilsky EJ, Negus SS, editors. Opiate Receptors and Antagonists. Totowa: Humana Press; 2009. pp. 541-9. [DOI: 10.1007/978-1-59745-197-0_28] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
43 Decock S, Roelandts R, Steenbergen WV, Laleman W, Cassiman D, Verslype C, Fevery J, Pelt JV, Nevens F. Cholestasis-induced pruritus treated with ultraviolet B phototherapy: an observational case series study. J Hepatol. 2012;57:637-641. [PMID: 22613002 DOI: 10.1016/j.jhep.2012.04.023] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
44 Li WX, Yan X, Shi CR, Zhang AP. Chlorambucil for patients with primary biliary cirrhosis. Cochrane Database Syst Rev. 2012;9:CD008714. [PMID: 22972125 DOI: 10.1002/14651858.cd008714.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
45 Eisendle K, Müller H, Ortner E, Talasz H, Graziadei I, Vogel W, Höpfl R. Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease. J Gastroenterol Hepatol. 2011;26:716-721. [PMID: 21155876 DOI: 10.1111/j.1440-1746.2010.06522.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
46 Chazouillères O. MARS: The ultimate warrior against pruritus of cholestasis? J Hepatol. 2010;53:228-229. [PMID: 20494469 DOI: 10.1016/j.jhep.2010.04.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
47 Düll MM, Wolf K, Vetter M, Dietrich P, Neurath MF, Kremer AE. Endogenous Opioid Levels Do Not Correlate With Itch Intensity and Therapeutic Interventions in Hepatic Pruritus. Front Med (Lausanne) 2021;8:641163. [PMID: 33937284 DOI: 10.3389/fmed.2021.641163] [Reference Citation Analysis]
48 Cheng B, Liu HW, Fu XB. Update on pruritic mechanisms of hypertrophic scars in postburn patients: the potential role of opioids and their receptors. J Burn Care Res 2011;32:e118-25. [PMID: 21747328 DOI: 10.1097/BCR.0b013e3182223c32] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
49 Bassari R, Koea JB. Jaundice associated pruritis: A review of pathophysiology and treatment. World J Gastroenterol 2015; 21(5): 1404-1413 [PMID: 25663760 DOI: 10.3748/wjg.v21.i5.1404] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
50 Silvagni E, Colì L, Stagni B, Stefoni S, Bolondi L. A case of intractable pruritus in Turner's syndrome successfully treated with molecular adsorbent recirculating system. Intern Emerg Med 2008;3:65-7. [PMID: 18273566 DOI: 10.1007/s11739-008-0094-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Nguyen DL, Juran BD, Lazaridis KN. Primary biliary cirrhosis. Best Pract Res Clin Gastroenterol. 2010;24:647-654. [PMID: 20955967 DOI: 10.1016/j.bpg.2010.07.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
52 Tian B, Wang XL, Huang Y, Chen LH, Cheng RX, Zhou FM, Guo R, Li JC, Liu T. Peripheral and spinal 5-HT receptors participate in cholestatic itch and antinociception induced by bile duct ligation in rats. Sci Rep 2016;6:36286. [PMID: 27824106 DOI: 10.1038/srep36286] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
53 Kremer AE, Beuers U, Oude-Elferink RP, Pusl T. Pathogenesis and treatment of pruritus in cholestasis. Drugs. 2008;68:2163-2182. [PMID: 18840005 DOI: 10.2165/00003495-200868150-00006] [Cited by in Crossref: 77] [Cited by in F6Publishing: 58] [Article Influence: 5.9] [Reference Citation Analysis]
54 Bunchorntavakul C, Reddy KR. Pruritus in chronic cholestatic liver disease. Clin Liver Dis 2012;16:331-46. [PMID: 22541702 DOI: 10.1016/j.cld.2012.03.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
55 Schaefer B, Schaefer F, Wittmer D, Engelmann G, Wenning D, Schmitt CP. Molecular Adsorbents Recirculating System dialysis in children with cholestatic pruritus. Pediatr Nephrol 2012;27:829-34. [PMID: 22083365 DOI: 10.1007/s00467-011-2058-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
56 Valour F, Durupt S, Khenifer S, Durieu I. Diagnostic value of anti-gp210 antibodies in primary biliary cirrhosis: a case-based review. BMJ Case Rep. 2013;2013:pii: bcr2013009803. [PMID: 23814122 DOI: 10.1136/bcr-2013-009803] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
57 Webb GJ, Rahman SR, Levy C, Hirschfield GM. Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross-disease cohort study. Aliment Pharmacol Ther 2018;47:1213-9. [PMID: 29468705 DOI: 10.1111/apt.14579] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
58 de Graaf KL, Lapeyre G, Guilhot F, Ferlin W, Curbishley SM, Carbone M, Richardson P, Moreea S, McCune CA, Ryder SD, Chapman RW, Floreani A, Jones DE, de Min C, Adams DH, Invernizzi P. NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid. Hepatol Commun 2018;2:492-503. [PMID: 29761166 DOI: 10.1002/hep4.1170] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]